Autoimmune Diseases  >>  Renflexis (infliximab-abda)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Renflexis (infliximab-abda) / Yuhan Corp, Biogen, Ewopharma, Samsung, Organon
NCT01936181 / 2012-005733-37: A Study Comparing SB2 to Remicade® in Subjects With Moderate to Severe Rheumatoid Arthritis Despite Methotrexate Therapy

Checkmark ACR-ARHP 2015: Rheumatoid arthritis
Oct 2015 - Oct 2015: ACR-ARHP 2015: Rheumatoid arthritis
Completed
3
584
Europe
Remicade (infliximab), SB2 (proposed biosimilar to infliximab)
Samsung Bioepis Co., Ltd.
Rheumatoid Arthritis
09/14
09/15

Download Options